SanBio Company Limited provided earnings guidance for the Fiscal Year Ending January 31, 2023. For the full year, the company expected Operating loss of JPY 8,131 million; Net loss attributable to owners of parent to be JPY 5,684 million and net loss per share of JPY 95.36.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,398 JPY | +27.32% | +40.08% | +99.15% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+99.15% | 469M | |
+16.81% | 122B | |
+20.01% | 115B | |
+21.22% | 26.64B | |
-23.49% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-18.67% | 15.49B | |
+61.55% | 14.83B | |
+3.31% | 13.67B |
- Stock Market
- Equities
- 4592 Stock
- News SanBio Company Limited
- SanBio Company Limited Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023